Organogenesis Holdings Inc. SEC filings ORGO

Organogenesis Holdings Inc. has 673 filings in SEC EDGAR's recent list, going back to Dec 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Organogenesis Holdings Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Material agreement
Aug 6, 2026 Aug 6, 2026
424B5 Prospectus supplement Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2026 Jun 15, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Jun 15, 2026
4 Insider transaction Apr 24, 2026 Jan 10, 2025
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4/A Amended statement of changes in beneficial ownership of securities Mar 3, 2026 Feb 18, 2026
4/A Amended statement of changes in beneficial ownership of securities Mar 3, 2026 Feb 18, 2026
4/A Amended statement of changes in beneficial ownership of securities Mar 3, 2026 Feb 18, 2026
4/A Amended statement of changes in beneficial ownership of securities Mar 3, 2026 Feb 18, 2026
4/A Amended statement of changes in beneficial ownership of securities Mar 3, 2026 Feb 18, 2026
4/A Amended statement of changes in beneficial ownership of securities Mar 3, 2026 Feb 18, 2026
4/A Amended statement of changes in beneficial ownership of securities Mar 3, 2026 Feb 18, 2026
3 Initial insider ownership Feb 27, 2026 Feb 18, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Officer or director change
Feb 23, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
8-K Current report
Material agreement
Dec 29, 2025 Dec 22, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 16, 2025 —
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 25, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 3, 2025 —
4 Insider transaction Nov 3, 2025 May 14, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 25, 2025 Sep 25, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 13, 2025 Aug 11, 2025
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations
Aug 7, 2025 Aug 5, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 26, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2025 Jun 23, 2025
4 Insider transaction Jun 6, 2025 Jun 4, 2025
ARS Annual report to shareholders May 12, 2025 Dec 31, 2024
DEF 14A Proxy statement May 12, 2025 Jun 23, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
PRE 14A Preliminary proxy statement Apr 29, 2025 Jun 23, 2025
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Mar 27, 2025 Mar 27, 2025
144 Notice of proposed sale Mar 17, 2025 —
4 Insider transaction Mar 12, 2025 Mar 9, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 4, 2025 Mar 1, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 13, 2025 —
4 Insider transaction Jan 13, 2025 Jan 9, 2025
4 Insider transaction Jan 13, 2025 Jan 9, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
3 Initial insider ownership Jan 3, 2025 Dec 31, 2024
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 3, 2025 —
424B3 Prospectus Dec 23, 2024 —
EFFECT Filing Dec 20, 2024 —
CORRESP Letter to the SEC Dec 20, 2024 —
UPLOAD Letter from the SEC Dec 20, 2024 —
S-3 Shelf registration Dec 19, 2024 —
4 Insider transaction Dec 16, 2024 Dec 13, 2024
4 Insider transaction Dec 12, 2024 Dec 10, 2024
4 Insider transaction Dec 9, 2024 Dec 5, 2024
144 Notice of proposed sale Dec 6, 2024 —
4 Insider transaction Dec 2, 2024 Nov 27, 2024
4 Insider transaction Dec 2, 2024 Nov 27, 2024
8-K Current report
Material agreement
Dec 2, 2024 Nov 27, 2024
D Filing Nov 27, 2024 —
8-K Current report
Material agreement, Other events
Nov 22, 2024 Nov 18, 2024
SC 13D Ownership over 5% (active) Nov 19, 2024 —
3 Initial insider ownership Nov 19, 2024 Nov 12, 2024
SC 13D/A Amended ownership over 5% (active) Nov 14, 2024 —
3 Initial insider ownership Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
4 Insider transaction Nov 14, 2024 Nov 12, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Nov 13, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
EFFECT Filing Aug 15, 2024 —
CORRESP Letter to the SEC Aug 13, 2024 —
UPLOAD Letter from the SEC Aug 13, 2024 —
S-3 Shelf registration Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Jul 18, 2024 Jul 16, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 21, 2024 Jun 20, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
3 Initial insider ownership Apr 29, 2024 Apr 19, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 Jun 20, 2024
8-K Current report
Other events
Apr 3, 2024 Apr 3, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Mar 29, 2024 Mar 28, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
SC 13G Ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 2, 2024 —
4 Insider transaction Jan 11, 2024 Jan 9, 2024
4 Insider transaction Jan 11, 2024 Jan 9, 2024
144 Notice of proposed sale Jan 9, 2024 —
144 Notice of proposed sale Jan 9, 2024 —
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 13, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 10, 2023 May 10, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEF 14A Proxy statement May 1, 2023 —
4 Insider transaction Apr 14, 2023 Apr 12, 2023
4 Insider transaction Apr 14, 2023 Apr 12, 2023
SC 13G/A Amended ownership over 5% (passive) Apr 6, 2023 —
4 Insider transaction Apr 4, 2023 Apr 1, 2023
4 Insider transaction Apr 4, 2023 Apr 1, 2023
4 Insider transaction Apr 4, 2023 Apr 1, 2023
4 Insider transaction Apr 4, 2023 Apr 1, 2023
4 Insider transaction Apr 4, 2023 Apr 1, 2023
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 1, 2023 Mar 1, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ORGO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Canton, MA
SEC filer status
Accelerated filer
SEC CIK
1661181
Former names
Avista Healthcare Public Acquisition Corp. (until Dec 10, 2018)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.